Gemcitabine: A Cornerstone in Cancer Therapy
Discover the chemical nuances and therapeutic power of Gemcitabine, a vital pharmaceutical intermediate.
Get a Quote & SampleProduct Core Value
Gemcitabine
Gemcitabine is a highly pure (>99%) pyrimidine nucleoside analog that plays a critical role as a pharmaceutical intermediate in the development of advanced cancer treatments. Its unique molecular structure and mechanism of action make it indispensable in modern chemotherapy.
- Understanding the gemcitabine synthesis process reveals intricate chemical engineering for high purity.
- The gemcitabine mechanism of action involves disrupting DNA synthesis, crucial for its cytotoxic effects.
- Gemcitabine CAS 95058-81-4 is a key identifier for sourcing and regulatory compliance in the pharmaceutical industry.
- Rigorous gemcitabine quality control ensures that the pharmaceutical intermediate meets stringent purity standards.
Advantages of Gemcitabine
Enhanced Efficacy in Combination Therapies
Gemcitabine's effectiveness is significantly amplified when used in combination therapies for various cancers, showcasing its versatility in tackling complex diseases and providing improved patient outcomes.
Critical Pharmaceutical Intermediate
As a gemcitabine pharmaceutical intermediate, it forms the foundational building block for many life-saving cancer drugs, highlighting its importance in the pharmaceutical supply chain.
High Purity for Safety and Efficacy
The specified gemcitabine purity of 99% is paramount for ensuring both the safety and efficacy of the final drug products, minimizing risks associated with impurities in cancer treatment.
Key Applications
Ovarian Cancer Treatment
Gemcitabine is a vital component in the treatment of advanced ovarian cancer, often used when platinum-based therapies have relapsed, demonstrating its role in gemcitabine cancer treatment protocols.
Breast Cancer Therapy
In metastatic breast cancer, Gemcitabine, when combined with other agents like paclitaxel, offers a crucial therapeutic option for patients who have not responded well to prior treatments.
Lung Cancer Management
Gemcitabine plays a role in treating advanced or metastatic non-small cell lung cancer, often administered alongside cisplatin, underscoring its utility in challenging respiratory oncological cases.
Pancreatic Cancer Treatment
For advanced or metastatic pancreatic cancer, Gemcitabine is a standard of care, particularly for patients pre-treated with fluorouracil, showcasing its application in gastrointestinal oncology.